Production of Protective Human Antipneumococcal Antibodies by Transgenic Mice with Human Immunoglobulin Loci

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2000 Mar 18

PMID 10722569

Citations 20

Authors

N D Russell

J R Corvalan

M L Gallo

C G Davis

L A Pirofski

Affiliations

Soon will be listed here.

Abstract

Infections with Streptococcus pneumoniae remain a significant cause of morbidity and mortality. To gain insight into structure-function relationships for human antibodies to pneumococcal capsular polysaccharide (PPS), we studied the response of transgenic mice reconstituted with human immunoglobulin loci, XenoMouse, to PPS antigens in a pneumococcal vaccine. Enzyme-linked immunosorbent assays of sera from mice vaccinated with a 23-valent pneumococcal vaccine revealed that they produced serotype-specific human antibodies, with the greatest response being to the PPS of serotype 3 (PPS 3). Molecular sequence analysis of three monoclonal antibodies (MAbs) to PPS 3 generated from lymphoid cells from mice vaccinated with a 23-valent pneumococcal vaccine or a PPS 3-bovine serum albumin conjugate revealed that they all used heavy-chain immunoglobulin genes from the V(H)3 family, two expressed light chain genes from the human Vkappa1 family, and one expressed a mouse lambda light chain. The protective efficacy of the two MAbs was examined in mice. A 10-microgram dose of both, and a 1-microgram dose of one, significantly prolonged survival from a lethal serotype 3 infection in CBA/N mice. Our data show that XenoMouse mice produced protective, serotype-specific human antibodies to PPS 3, and they lend support to the proposal that these animals represent a useful model to study the human antibody response to PPS antigens.

Citing Articles

Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.

Babb R, Doyle C, Pirofski L Microbiol Spectr. 2021; 9(3):e0144621.

PMID: 34756090 PMC: 8579928. DOI: 10.1128/Spectrum.01446-21.

MCR Expression Conferring Varied Fitness Costs on Host Bacteria and Affecting Bacteria Virulence.

Li W, Liu Z, Yin W, Yang L, Qiao L, Song S Antibiotics (Basel). 2021; 10(7).

PMID: 34356793 PMC: 8300855. DOI: 10.3390/antibiotics10070872.

A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies.

Ozdilek A, Huang J, Babb R, Paschall A, Middleton D, Duke J mBio. 2021; 12(3):e0080021.

PMID: 34061603 PMC: 8262990. DOI: 10.1128/mBio.00800-21.

The smart targeting of nanoparticles.

Friedman A, Claypool S, Liu R Curr Pharm Des. 2013; 19(35):6315-29.

PMID: 23470005 PMC: 4016770. DOI: 10.2174/13816128113199990375.

Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.

Westerink M, Schroeder Jr H, Nahm M Aging Dis. 2012; 3(1):51-67.

PMID: 22500271 PMC: 3320805.

References

van Dam J, Fleer A, Snippe H . Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie Van Leeuwenhoek. 1990; 58(1):1-47. DOI: 10.1007/BF02388078. View

Barrett D, Lee C, Ammann A, Ayoub E . IgG and IgM pneumococcal polysaccharide antibody responses in infants. Pediatr Res. 1984; 18(11):1067-71. DOI: 10.1203/00006450-198411000-00001. View

Scott M, Crimmins D, McCourt D, Chung G, Schable K, Thiebe R . Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. IV. The less frequently expressed VL are heterogeneous. J Immunol. 1991; 147(11):4007-13. View

Briles D, Crain M, Gray B, Forman C, Yother J . Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun. 1992; 60(1):111-6. PMC: 257510. DOI: 10.1128/iai.60.1.111-116.1992. View

Kirkham P, Mortari F, Newton J, Schroeder Jr H . Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J. 1992; 11(2):603-9. PMC: 556492. DOI: 10.1002/j.1460-2075.1992.tb05092.x. View

Adderson E, Shackelford P, Insel R, Quinn A, Wilson P, Carroll W . Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations. J Clin Invest. 1992; 89(3):729-38. PMC: 442915. DOI: 10.1172/JCI115649. View

Briles D, Forman C, Crain M . Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect Immun. 1992; 60(5):1957-62. PMC: 257101. DOI: 10.1128/iai.60.5.1957-1962.1992. View

Garg M, Subbarao B . Immune responses of systemic and mucosal lymphoid organs to Pnu-Imune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant. Infect Immun. 1992; 60(6):2329-36. PMC: 257162. DOI: 10.1128/iai.60.6.2329-2336.1992. View

Janoff E, Breiman R, Daley C, Hopewell P . Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med. 1992; 117(4):314-24. DOI: 10.7326/0003-4819-117-4-314. View

10.

Adderson E, Azmi F, Wilson P, Shackelford P, Carroll W . The human VH3b gene subfamily is highly polymorphic. J Immunol. 1993; 151(2):800-9. View

11.

Berberian L, Goodglick L, Kipps T, Braun J . Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science. 1993; 261(5128):1588-91. DOI: 10.1126/science.7690497. View

12.

Rock E, Sibbald P, Davis M, Chien Y . CDR3 length in antigen-specific immune receptors. J Exp Med. 1994; 179(1):323-8. PMC: 2191339. DOI: 10.1084/jem.179.1.323. View

13.

Cox J, Tomlinson I, Winter G . A directory of human germ-line V kappa segments reveals a strong bias in their usage. Eur J Immunol. 1994; 24(4):827-36. DOI: 10.1002/eji.1830240409. View

14.

Lucas A, Larrick J, Reason D . Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide. Infect Immun. 1994; 62(9):3873-80. PMC: 303043. DOI: 10.1128/iai.62.9.3873-3880.1994. View

15.

Green L, Hardy M, Tsuda H, Louie D, Mendez M, Abderrahim H . Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat Genet. 1994; 7(1):13-21. DOI: 10.1038/ng0594-13. View

16.

Westerink M, Giardina P, Apicella M, Kieber-Emmons T . Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc Natl Acad Sci U S A. 1995; 92(9):4021-5. PMC: 42094. DOI: 10.1073/pnas.92.9.4021. View

17.

Mond J, Lees A, Snapper C . T cell-independent antigens type 2. Annu Rev Immunol. 1995; 13:655-92. DOI: 10.1146/annurev.iy.13.040195.003255. View

18.

Pirofski L, Lui R, Deshaw M, Kressel A, Zhong Z . Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect Immun. 1995; 63(8):3005-14. PMC: 173409. DOI: 10.1128/iai.63.8.3005-3014.1995. View

19.

Aaberge I, Eng J, Lermark G, Lovik M . Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb Pathog. 1995; 18(2):141-52. DOI: 10.1016/s0882-4010(95)90125-6. View

20.

Jakobovits A . Production of fully human antibodies by transgenic mice. Curr Opin Biotechnol. 1995; 6(5):561-6. DOI: 10.1016/0958-1669(95)80093-x. View